Wuhan Da'an Pharmaceutical

Wuhan Da'an Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and large-scale production of lipid emulsion injections and complex parenteral formulations. As a core subsidiary of Grand Pharmaceutical Group, the company has established itself as a leader in the domestic market for specialty injectables used in cardiovascular care, analgesia, and anesthesiology. Its flagship products include Alprostadil lipid emulsion for peripheral vascular diseases and Flurbiprofen Axetil for postoperative pain management. The company operates advanced GMP-certified manufacturing facilities in Wuhan's Optical Valley, leveraging proprietary formulation technologies to enhance the stability and delivery of poorly soluble drugs.